1. Home
  2. EML vs PLX Comparison

EML vs PLX Comparison

Compare EML & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eastern Company (The)

EML

Eastern Company (The)

N/A

Current Price

$25.25

Market Cap

152.9M

ML Signal

N/A

Logo Protalix BioTherapeutics Inc. (DE)

PLX

Protalix BioTherapeutics Inc. (DE)

N/A

Current Price

$2.69

Market Cap

182.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EML
PLX
Founded
1858
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
152.9M
182.9M
IPO Year
1995
1996

Fundamental Metrics

Financial Performance
Metric
EML
PLX
Price
$25.25
$2.69
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$12.00
AVG Volume (30 Days)
9.7K
656.9K
Earning Date
05-12-2026
05-12-2026
Dividend Yield
1.98%
N/A
EPS Growth
185.40
N/A
EPS
1.04
0.27
Revenue
$248,970,345.00
$52,744,000.00
Revenue This Year
$19.05
$36.81
Revenue Next Year
N/A
N/A
P/E Ratio
$24.27
$9.85
Revenue Growth
N/A
N/A
52 Week Low
$17.61
$1.60
52 Week High
$29.91
$3.19

Technical Indicators

Market Signals
Indicator
EML
PLX
Relative Strength Index (RSI) 49.35 61.82
Support Level $24.18 $2.59
Resistance Level $27.16 $3.03
Average True Range (ATR) 1.20 0.10
MACD -0.21 0.01
Stochastic Oscillator 37.88 83.72

Price Performance

Historical Comparison
EML
PLX

About EML Eastern Company (The)

The Eastern Co manages industrial businesses that design, manufacture, and sell engineered solutions to the industrial market. The company manages the financial, operational, and strategic performance of its businesses to increase cash generation, operating earnings, and long-term shareholder value. It has one reportable segment: Engineered Solutions, which provides engineered solutions mainly for the commercial transportation and logistics markets. This segment offers a diverse product line of custom and standard vehicular and industrial hardware, including turnkey returnable packaging solutions, blow molds, compression latches, draw latches, hinges, camlocksaccess, mirrors, and mirror-cameras, among other products. Geographically, the group derives maximum revenue from the United States.

About PLX Protalix BioTherapeutics Inc. (DE)

Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.

Share on Social Networks: